| 000 | 02976nam a22004935i 4500 | ||
|---|---|---|---|
| 001 | 978-3-7091-1300-4 | ||
| 003 | DE-He213 | ||
| 005 | 20140220082524.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 131125s2014 au | s |||| 0|eng d | ||
| 020 |
_a9783709113004 _9978-3-7091-1300-4 |
||
| 024 | 7 |
_a10.1007/978-3-7091-1300-4 _2doi |
|
| 050 | 4 | _aQR180-189.5 | |
| 072 | 7 |
_aMJCM _2bicssc |
|
| 072 | 7 |
_aMED044000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.079 _223 |
| 100 | 1 |
_aKlink, Magdalena. _eeditor. |
|
| 245 | 1 | 0 |
_aInteraction of Immune and Cancer Cells _h[electronic resource] / _cedited by Magdalena Klink. |
| 264 | 1 |
_aVienna : _bSpringer Vienna : _bImprint: Springer, _c2014. |
|
| 300 |
_aX, 263 p. 21 illus., 17 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aImmune cells within tumor microenvironment -- Tumor-stroma interaction and cancer progression -- The role of tumor associated macrophages (TAMs) in tumor progression -- Dendritic cells dysfunction and tumor progression -- Myeloid-derived suppressor cells (MDSC) and tumor growth -- Tumor-infiltrating lymphocytes and their role in solid tumor progression -- Polymorphonuclear neutrophils and tumor: friend or foe? -- Cancer immunosurveillance and immunoediting -- Adoptive T cell immunotherapy – Perfecting self-defense -- Monoclonal antibodies to CTLA4 with focus on ipilimumab. | |
| 520 | _aThe tumor environment is a dynamic network that includes cancer cells, immune cells, fibroblasts, endothelial cells, extracellular matrix, cytokines and receptors. The aim of this book is to summarize the role of these components, especially immune cells, in tumor suppression and/or progression and describe in detail why tumor cells can survive and spread in spite of the antitumor response of immune cells. Since immunotherapy is an attractive approach to cancer therapy, this book also provides information on the two main strategies: monoclonal antibodies and adaptive T cell immunotherapy, with a focus on recent human clinical trials. The book provides a state-of-the-art, comprehensive overview of immune cells in cancer and is an indispensable resource for scientists and medical doctors working and/or lecturing in the field of cancer research and immunology. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aOncology. | |
| 650 | 0 | _aImmunology. | |
| 650 | 0 | _aVaccines. | |
| 650 | 0 | _aCytokines. | |
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aImmunology. |
| 650 | 2 | 4 | _aCancer Research. |
| 650 | 2 | 4 | _aVaccine. |
| 650 | 2 | 4 | _aCytokines and Growth Factors. |
| 650 | 2 | 4 | _aMolecular Medicine. |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783709112991 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-7091-1300-4 |
| 912 | _aZDB-2-SBL | ||
| 999 |
_c93650 _d93650 |
||